Beneski Benjamin Machinas 4

What Happened

• Beneski Benjamin Machinas, SVP and Chief Technical Officer of Allogene Therapeutics (ALLO), sold 2,867 shares on 2026-03-31 at $2.50 per share, generating $7,168 in proceeds. The filing classifies the transaction as a sale (S).

Key Details

• Transaction date and price: 2026-03-31 — 2,867 shares sold at $2.50 each.
• Total value: $7,168.
• Shares owned after transaction: Not reported in this Form 4.
• Footnote: The sale was a "sell to cover" to satisfy tax withholding on vested restricted stock units, mandated by the issuer's equity plan (footnote F1). This is not a discretionary trade by the reporting person.
• Filing: Form 4 filed 2026-04-02; this filing is within the typical two-business-day SEC reporting window (timely).

Context

• Sell-to-cover transactions are routine administrative sales to pay taxes on vesting equity and generally do not indicate an insider's view of the company's prospects.